Search by Journal
- HOME
- > Search by Journal
- > Journal of Japanese Society of Pharmaceutical Oncology
Journal of Japanese Society of Pharmaceutical Oncology
Volume 11, Issue / 2019


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
A Case of Thrombotic Microangiopathy during Combination Therapy with Gemcitabine and nab-paclitaxel Ayako Kobayashi1, Junpei Kato1, Shinya Tatsuta1, Keisuke Ono2, Shingo Miyamoto3, Yuan Bee4, Kota Ishida1, Kenshi Suzuki1 Journal of Japanese Society of Pharmaceutical Oncology 11: 1-6, 2019. |
---|
![]() |
Mercaptopurine hydrate powder exposure in a disc-type powder dispensing machine. Yoshihiro Yamamoto1, Miku Sakurai1, Norio Watanabe2, Takashi Osada2, Yasuhiro Toda1, Keiko Yamamura2, Toshiya Taniguchi3, Magoichi Sako3 Journal of Japanese Society of Pharmaceutical Oncology 11: 7-12, 2019. |
---|
![]() |
Examination of effect predictor of non-small cell lung cancer patient administered Nivolumab Kengo Umehara1, Kaori Yama3, Keisuke Goto1, Yasuka Okazaki1, Azusa Wakamoto1, Tae Hatsuyama1, Osamu Honjo2, Hideki Sato3 Journal of Japanese Society of Pharmaceutical Oncology 11: 13-21, 2019. |
---|
![]() |
Survey of hospital pharmacist duties in outpatient cancer treatment department 堤大輔1, 花香淳一2, 脇本麻美3, 村田勇人4, 丹原由希5, 中田千博6, 河野友昭7, 林啓文8, 川澄賢司6, 櫻井洋臣9, 濃沼政美10, 近藤直樹3 Journal of Japanese Society of Pharmaceutical Oncology 11: 22-27, 2019. |
---|
![]() |
Lecture Series of Research Method : (2) How to write a research paper Basic Rules for Writing a Research Paper Yukiyoshi Fujita* Journal of Japanese Society of Pharmaceutical Oncology 11: 28-34, 2019. |
---|
![]() |
No1 Febrile neutropenia 編集部 Journal of Japanese Society of Pharmaceutical Oncology 11: 35-42, 2019. |
---|
![]() |
No1 Antineoplastic / Anti-PD-L1 humanized monoclonal antibody TECENTRIQ (R) Intravenous Infusion 1200 mg Atezolizumab (genetical recombination) injection 中外製薬株式会社 Journal of Japanese Society of Pharmaceutical Oncology 11: 43-49, 2019. |
---|